Hello, We Are Xentria

The name Xentria stems from the word “centrality”

We are focused on becoming a critical leader in the biopharma industry through a strong portfolio of products having purpose for patients. Driven to treat the clinical and social burdens of diseases while fostering sustainable growth.

See Our Pipeline Get In Touch

Why Biologics?

The current medicine landscape is dominated by “classic” small molecules (drugs created in a lab using traditional drug discovery techniques). While traditional medicines, including small molecule medicines, provide a great benefit to populations, they need to have a well-defined structure to be effective therapies. As such, the scientific community has turned to what we now refer to as Biologics.

Biologics are larger molecule medicines that are produced by genetically engineering microorganisms to produce specific proteins. The benefit with larger molecule drugs, specifically biologics, is that they can exert their effects on a broader spectrum of targets.

Biologics vs. Traditional Medicines




  • Larger molecules
  • High molecular weight


  • Impossible to create an exact replica of original protein
  • Complicated, multistep manufacturing process

Traditional Medicine



  • Small molecules
  • Low molecular weight


  • Standard, well understood chemistry
  • Repeatable manufacturing process

Our Pipeline

Xentria’s goal is to provide effective therapies to countless patients in need. There are several projects ongoing.

Come Check It Out!


Xentria is an evergrowing team in a dynamic industry with opportunity for growth.

Come Join Our Team!

Contact Us

We would love to hear from you!

Address: 8700 W. Bryn Mawr, Suite 600S, Chicago, IL 60631

Phone: (224) 443 4615

Contact: Contact